Active, not recruitingNCT04036799

PRecIsion Medicine in CardiomyopathY

Studying Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Hospital for Sick Children
Enrollment
572 target
Eligibility
0-18 years · All sexes
Timeline
20172026

Collaborators

Stanford University · Children's Hospital of Philadelphia · New York Presbyterian Hospital · University of Texas Southwestern Medical Center · University of Michigan · Children's Hospital Medical Center, Cincinnati · Provincial Health Services Authority British Columbia · Stollery Children's Hospital · Children's Hospital of Eastern Ontario · Royal Children's Hospital · Children's Healthcare of Atlanta · Primary Children's Hospital · Baylor College of Medicine · The Cleveland Clinic · Monroe Carell Jr. Children's Hospital at Vanderbilt · Children's Hospital Colorado · Indiana University Health · OHSU Doernbecher Children's Hospital · Children's Hospital Los Angeles

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04036799 on ClinicalTrials.gov

Other trials for Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome

Additional recruiting or active studies for the same condition.

See all trials for Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome

← Back to all trials